9 results
Dyspnea - Considerations with Malignancy
Directly Malignancy Related:
 - Lymphangitic spread to lung
 - Malignant pleural effusion
Dyspnea - Considerations ... - Malignant pleural ... effusion - Malignant ... - Lung metastases ... #algorithm #differential
Fibrinous septations in Malignant Pleural Effusion (MPE) - Lung POCUS
 • can be triggered by thoracenteses
Pleural Effusion ... (MPE) - Lung POCUS ... prospective e/o dyspnea ... #Pleural #Effusion ... #MPE #Lung #POCUS
►
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
known or suspected malignant ... pleural effusion ... goals of assessing lung ... #Malignant #Pleural ... #Algorithm #Management
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... thickened, irregular pleural ... BLUE #protocol #Algorithm ... #Dyspnea #CriticalCare ... #POCUS #Lung #Pulmonary
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... with A-lines ... thickened, irregular pleural ... line is an equivalent ... www.grepmed.com/images/11924/dyspnea-criticalcare-pulmonary-algorithm-pocus
►
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... thickened, irregular pleural ... BLUE #protocol #Algorithm ... #Dyspnea #CriticalCare ... #POCUS #Lung #Pulmonary
►
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
with CTD, drugs, malignancy ... History: cough, dyspnea ... pattern, irregular lines ... Rare: pleural effusions ... , pleural thickening
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
known or suspected malignant ... pleural effusion ... goals of assessing lung ... and relief of dyspnea ... #Algorithm #Effusion
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
and exudative pleural ... effusions • Acute ... Dyspnea 3. ... • Reticular + Nodular ... embolism - Malignancy